연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
911. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells.
Kim TY, Kim IS, Jong HS, Lee JW, Kim TY, Jung M, Bang YJ.
Exp Mol Med. 2008 Dec 31;40(6):639-46.
Link
910. Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation.
Hyun J, Kim HK, Kim JE, Lim MG, Jung JS, Park S, Cho HI.
Thromb Res. 2009 May;124(1):75-9. Epub 2009 Jan 21.
Link
909. Prognostic value of immature platelet fraction and plasma thrombopoietin in disseminated intravascular coagulation.
Hong KH, Kim HK, Kim JE, Jung JS, Han KS, Cho HI.
Blood Coagul Fibrinolysis. 2009 Sep;20(6):409-14.
Link
908. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW, Kim HK, Kim JE, Park S, Cho HI.
Thromb Res. 2009 Feb;123(4):565-72. Epub 2008 May 13.
Link
907. Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Kim JS, Kim MA, Kim TM, Lee SH, Kim DW, Im SA, Kim TY, Kim WH, Yang HK, Heo DS, Bang YJ, Lee KU, Choe KJ, Kim NK.
Br J Cancer. 2009 Mar 10;100(5):732-8.
Link
906. Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells.
Yoon YK, Kim HP, Han SW, Hur HS, Oh do Y, Im SA, Bang YJ, Kim TY.
Mol Cancer Ther. 2009 Sep;8(9):2526-36. Epub 2009 Sep 15.
Link
905. Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.
Kim WY, Jeon YK, Kim TM, Kim JE, Kim YA, Lee SH, Kim DW, Heo DS, Kim CW.
Ann Oncol. 2009 Oct;20(10):1688-96. Epub 2009 Jun 19.
Link
904. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer.
Kim BK, Lee JW, Park PJ, Shin YS, Lee WY, Lee KA, Ye S, Hyun H, Kang KN, Yeo D, Kim Y, Ohn SY, Noh DY, Kim CW.
Breast Cancer Res. 2009;11(2):R22. Epub 2009 Apr 28
Link
903. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
Cho JA, Lee YS, Kim SH, Ko JK, Kim CW.
Cancer Lett. 2009 Mar 18;275(2):256-65. Epub 2008 Nov 25.
Link
902. Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean Gynecologic Oncology Group.
Lee TS, Kim JW, Kim TJ, Cho CH, Ryu SY, Ryu HS, Kim BG, Lee KH, Kim YM, Kang SB; Korean Gynecologic Oncology Group.
Gynecol Oncol. 2009 Oct;115(1):26-31. Epub 2009 Jul 26.
Link